Universal Time: 15:30  |  Local Time: 15:30 (0h GMT)
Select your timezone:

Sun Sep 13

00:00 Symposium: Lessons Learned about COVID-19
105.4 Immunogenetics (HLA and ABO)
Lori Jeanne West, Canada
105.6 Global Impact of COVID-19 on Transplantation
Alexandre Loupy, France
105.1 Virology, Epidemiology and Clinical Course
Olivia S. Kates, United States
105.2 Organ Specific Involvement of COVID-19
Aneesha Anand Shetty, United States
105.3 Diagnostics:  PCR, Antigen Detection and Serology 
Robin Patel, United States
105.5 Therapeutics & Vaccines
Michael G. Ison, United States
00:00 Symposium: Transplanting in the Era of COVID-19
110.2 When a Recipient with COVID-19 Can Proceed to Transplant
Paolo Antonio Grossi, Italy
110.1 Donor Screening and the Risk of Virus Transmission
Thomas D. Mone, United States
110.4 Transplantation in the Hot Zone
Jean C. Emond, United States
110.3 Lung Transplantation for COVID-19
Jingyu Chen, People's Republic of China
110.5 Transplantation and Ethical Issues in the COVID Era: Doing the right thing depends on location, resources and disease burden
Peter G. Stock, United States
22:00 - 23:30 Workshop Session: An Overview of Organ-Specific Transplantation in Children (diagnoses, procedures, outcome)
Discussion and Q&A
- -,
202.2 Liver
Winita Hardikar, Australia
202.1 Kidney
Katherine Twombley, United States
202.3 Thoracic
Jonathan Johnson, United States
202.4 Pediatric Intestinal Transplantation
George V. Mazariegos, United States
23:30 - 00:15 Oral Abstracts Session: Innate and Adaptive Immunity
211.1 Gasdermin-D mutation is protective against renal ischemia reperfusion injury
Jennifer Li, Australia
211.5 (P-2.74 in Journal) Oral administration of nano-sized silicon particles attenuates oxidative stress and ischemia-reperfusion injury in a rat model: A novel hydrogen administration method
Masataka Kawamura, Japan
211.3 Modulation of the IL-33/ST2 axis for regulatory T cell therapy in transplantation
Kento Kawai, United Kingdom
211.4 Development of fully differentiated pancreatic organoids from hiPSCs for type 1 diabetes cell therapy
Giuseppe Pettinato, United States

Mon Sep 14

00:15 - 02:00 State-of-the-Art Session: Tissue-Resident Lymphocytes
220.1 Formation and plasticity of tissue resident memory populations in human allografts revealed by single cell analysis and serial TCR sequencing
Megan Sykes, United States
220.2 Antigen presentation by tissue resident APC
Adrian E. Morelli, United States
220.3 Reshaping T cell memory with lymphoablation
Anna Valujskikh, United States
06:00 - 07:30 Workshop Session: Intestinal Rehabilitation and Transplantation: A step in the future!
242.2 Cost-efficiency of intestinal transplantation?
Emilio Canovai, Belgium
242.1 The role of glucagon-like Peptide-2 analogues in intestinal rehabilitation
Palle Bekker Jeppesen, Denmark
242.3 Living donation intestinal transplantation
Taizo Hibi, Japan
242.4 Fascia transplantation and pre-op embolization, novel techniques that change the field of intestinal transplantation?
Irum I Amin, United Kingdom
07:30 - 08:15 Oral Abstracts Session: Kidney Transplantation: Underlying diseases and infections
250.1 Cryptococcoma due to Cryptococcus albidus of a transplant kidney in a patient presenting with recurrent urinary tract infection: A clinical and metagenome sequencing study
Ziyan Yan, People's Republic of China
250.4 H1N1: A forgotten and mysterious entity in post renal transplant patients
Sanshriti Chauhan, India
250.3 DEEPGRAFT, a deep learning algorithm to classify kidney transplant diseases from digital whole slide biopsy images
Jesper Kers, Netherlands
250.2 Relationship between circulatory T follicular helper cells and CMV infection in kidney transplant recipients
Patricia Suàrez-Fernández, Spain
07:30 - 08:15 Oral Abstracts Session: Immune Regulation and Outcomes
251.2 Discovery of pMHC epitopes for directly alloreactive T cells
Eric Taeyoung ES Son, Australia
251.1 Elucidating the role of hypoxia in regulatory T cell function
Marie Sion, United Kingdom
251.3 The Prediction of Kidney Allograft Acute Rejection Based on Recipient Peripheral Blood Whole Transcriptome Profiling and Three mRNA Molecular Signatures
Liao Minxue, People's Republic of China
251.4 Myeloid derived suppressor cells (MDSC) in kidney recipients: Identification of CD25+eMDSC, and augmentation of monocytic-MDSC early after transplantation in patients later developing cancer
Alberto Utrero-Rico, Spain
08:15 - 10:00 State-of-the-Art Session: Managing Immunosuppression When Things Go Wrong
261.1 Managing IS in recipients with a failing graft
Sangho Lee, Korea
261.3 Managing IS in recipients treated for malignancies
Daniel Seron, Spain
261.2 Managing IS in recipients with complex infections
Peter Chin-Hong, United States
08:15 - 10:00 State-of-the-Art Session: Banff 2019 Update for Allograft Rejection
262.1 Liver (morphology)
Andrew Clouston, Australia
262.4 Kidney (molecular)
Carmen Lefaucheur, France
262.3 Kidney (morphology)
Hyeon Joo Jeong, Korea
262.2 Liver (molecular phenotyping)
Alberto Sanchez-Fueyo, United Kingdom
14:30 - 15:15 Oral Abstracts Session: Biomarkers and Omics
281.3 Single cell transcriptomic analysis for a better understanding of human CD8+ regulatory T cells
Céline Serazin, France
281.1 Transplantation of older organs transfers senescence
Jasper Iske, Germany
281.5 (P-2.125 in Journal) TCR repertoire sequencing of total T cells and circulating follicular helper T cells in kidney transplant recipients
Patricia Almendro Vázquez, Spain
281.2 Diagnosis of kidney transplant rejection by tracking donor-reactive T-cell clones in the post-transplant biopsy, blood and urine samples
Joseph R. Leventhal, United States
15:15 - 17:00 State-of-the-Art Session: Social Media for Scientists
291.3 Impact of social media on research dissemination
Carla C. Baan, Netherlands
291.1 Introduction and creating networks
Frank JMF Dor, United Kingdom
291.2 Healthcare and patient education
Macey L. Henderson, United States
22:00 - 23:30 Workshop Session: What the ID Doc should know about …
302.4 Rejection in intestinal transplant
Gabriel E. Gondolesi, Argentina
302.1 CLAD
Gregory I Snell, Australia
302.2 Bilomas
Prema Raj Jeyaraj, Singapore
302.3 Delayed allograft function after renal transplant
Roslyn B Mannon, United States
23:30 - 00:15 Oral Abstracts Session: Experimental and Preclinical Immunosuppression
312.2 Targeting inflammatory monocytes by immune-modifying nanoparticles prevents acute kidney allograft rejection
Christina Lai, Australia
312.4 ABO self-tolerance in a mouse model: Evidence of tolerance at B cell but not T cell level
Ibrahim Adam, Canada
312.1 Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage CSF (GM-CSF) administration enriches for highly suppressive CD4+CD45RA-Foxp3hi cells in leukapheresis products of rhesus monkeys
Kazuki Sasaki, United States
312.3 Carfilzomib and lulizumab-based desensitization prolongs allograft survival in sensitized non-human primates kidney transplantation model
Jean Kwun, United States
23:30 - 00:15 Oral Abstracts Session: Advances in Liver and Intestinal Transplantation in Children
313.2 Ionizing radiation exposure review in children with intestinal failure
Ana c Grasso, Argentina
313.4 Significance of sarcopenia in infants with pediatric liver transplantation for biliary atresia
Masahiro Takeda, Japan
313.1 Should steatotic livers be transplanted into pediatric recipients?
Malcolm MacConmara, United States
313.3 Marginal livers have excellent outcomes in pediatric patients with metabolic liver disease
Christine Hwang, United States

Tue Sep 15

00:15 - 02:00 State-of-the-Art Session: Timely Topics in Intestine and Multivisceral Transplantation
322.2 Novel biomarkers and graft monitoring for ITx recipients
Gabriel E. Gondolesi, Argentina
322.1 DSA and AMR In ITx recipients: Monitoring, prevention, and treatment strategies
Debra Sudan, United States
322.3 Pediatric intestinal transplantation
Cal Matsumoto, United States
08:15 - 10:00 State-of-the-Art Session: The Future is Now… Immune Regulation in Transplantation
360.1 The Regulation of Immune Tolerance by FOXP3 - basic
Ling Lu, People's Republic of China
360.2 Intragraft immune regulation protects transplants under sub-therapeutic immunosuppression
Paloma Riquelme, Germany
James Alexander Hutchinson, Germany
360.3 Clinical experience of Treg therapy
Fadi Issa, United Kingdom
14:30 - 15:15 Oral Abstracts Session: Immune Regulation and Tolerance I
381.4 Single cell immune profiling of human intestinal allografts reveals heterogeneity and alloreactivity of recipient resident memory T cells in association with graft outcomes
Jianing Fu, United States
381.1 Treg use the PD-1-PD-L1 axis for lymphatic transendothelial migration
Wenji Piao, United States
381.2 Donor liver plasmacytoid dendritic cells promote effector T cell exhaustion and augment Treg responses in mouse spontaneous liver transplant tolerance
Ryosuke Nakano, United States
381.3 Lymph node stromal laminin alpha 5 regulates adaptive immunity
Lushen Li, United States
14:30 - 15:15 Oral Abstracts Session: Anesthesia Management and Intestine Multivisceral
383.4 Grafted colon in intestinal transplantation: Does it make a difference in patients outcome?
Javier Serradilla, Spain
383.3 Luminal preservation with a polyethylene glycol-based solution alleviates mucosal damage in human intestines
John M Softeland, Sweden
383.2 Impact of enhanced recovery after surgery (ERAS) protocols on robotic living kidney donor and recipient outcomes
Amit Sharma, United States
383.1 Continuous peri-operative regional analgesia by asymmetrical Erector Spinae Plane Blocks on live liver donors for liver resection: A cases serie retrospective analysis
Viet Tuan Vu, Viet Nam

Wed Sep 16

00:15 - 02:00 State-of-the-Art Session: WHO Designation 2020 ‘Year of the Nurse’: Scope of Work & Contributions made by Tx Nurses
422.1 Psychosocial needs of living donors
Dianne LaPointe Rudow, United States
422.2 Nurse transplant coordinator roles in Japan
Etsuko Soeda, Japan
422.3 Nurse transplant coordinator roles in Korea
Young-Jin Wang, Korea
422.4 Nursing ethics in organ donation and transplantation
Melanie M Robinson, Australia
07:30 - 08:15 Oral Abstracts Session: Organ Preservation and Reperfusion Injury / Repair
452.1 Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, improves donor heart recovery after prolonged cold storage in an isolated working rat heart model
Jeanette E. Villanueva, Australia
452.2 A single-centre, five-year experience with DCD heart transplantation
Sarah E Scheuer, Australia
452.3 (P-4.59 in Journal) NAPLES study (Normothermic machine perfusion of the liver to enable the sickest first): Preliminary results
Hanns Lembach, United Kingdom
452.4 Enhanced functional recovery of hearts donated after circulatory death (DCD) with ante-mortem heparin.
Ling Gao, Australia

WebApp Sponsor

© 2024 TTS 2020